// App-Quantinova.ai

77 : ClaPD (Clarithromycin, Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma

Researchers

Presenter

  • Angelique Boyer

Principal Investigators

  • Adriana C Rossi

  • David Jayabalan

  • Scott A Ely

  • Morton Coleman

  • Selina Chen-Kiang

  • Ruben Niesvizky

  • Manan Shah

  • Roger N Pearse

  • Faiza Zafar

  • Karen Pekle

  • Linda Tegnestam

  • Erlinda A Sacris

  • June Greenberg

  • Stephanie Speaker

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pulmonary embolism

  • Venous thrombosis

  • Multiple Myeloma

  • Hyperglycemia

  • Neutropenia

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • Biaxin

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pomalidomide

  • CC-4047

  • Lenalidomide

  • Bortezomib

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • pharmacodynamics

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim